X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Genomics Market Growth In India To Accelerate Affordability

    EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

    WHO Utilizes Pathogen Genomics For Global Disease Protection

    Concerns Rise Over Shortage of Medical Products In The USA

    Key Areas For AI/ML Drug Development – FDA Discussion Paper

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Rising Pharmaceuticals Demand Drives Tablet Coatings Market

    Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

    Particle Size Distribution Real-Time Monitoring With PEACE

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Genomics Market Growth In India To Accelerate Affordability

    EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

    WHO Utilizes Pathogen Genomics For Global Disease Protection

    Concerns Rise Over Shortage of Medical Products In The USA

    Key Areas For AI/ML Drug Development – FDA Discussion Paper

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Rising Pharmaceuticals Demand Drives Tablet Coatings Market

    Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

    Particle Size Distribution Real-Time Monitoring With PEACE

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Switzerland Emerges As The Headquarters For European Biotech

Content Team by Content Team
25th May 2023
in Facilities & Operation, News

Analysis shows Switzerland has become the chosen headquarters for 20 per cent of European biotech companies. Out of a total of 265 companies that have settled in Switzerland, 63 of them are in the biotech sector, making it the second most significant industry after ICT. This trend is confirmed by statistics from the Swiss federal government in 2022.

A notable aspect is that 23 US companies have established themselves in Basel, Geneva, Zurich, or Lucerne, with several of them being biotech companies that independently market their innovative therapies without extensive support from large pharmaceutical companies. These companies select Switzerland as their European hub.

In preparation for their European launch, emerging biotech companies, responsible for an impressive 65 percent of the molecules in the research and development pipeline in 2022, have made collective decisions regarding infrastructure. These decisions encompass factors such as the engagement model, geographic footprint and structure, degree of centralization, and extent of role specialization.

Switzerland’s appeal to European biotech companies can be attributed to several reasons. Firstly, it offers a business-friendly environment that attracts these companies. Additionally, the country possesses a strong talent pool, including individuals with relevant launch experience at big pharma or other commercial-stage biotech companies. Swissmedic plays a crucial role in supporting innovation and accelerating the approval process for new drugs, even before they are ready for commercialization. This contributes to strengthening Switzerland’s research hub.

Swiss-based biotech companies enjoy a 25 percent higher availability rate for their medicines in European markets compared to the average biotech launches of the past five years. This has led to a growing interest in the Swiss ecosystem from biotech companies, particularly in the last decade. Here also, Swissmedic plays a crucial role in enhancing the Swiss research hub by providing support for innovation and expediting the approval process for new drugs well in advance of their commercialization.

With the assistance of Swissmedic, Switzerland fosters controlled and swift global access to promising products for drug developers through collaborative partnerships with international counterparts. This ensures that patients can benefit quickly from safe and high-quality innovative therapies.

Previous Post

Genomics Market Growth In India To Accelerate Affordability

Related Posts

News

Genomics Market Growth In India To Accelerate Affordability

24th May 2023
FDA Approvals

EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

24th May 2023
FDA Approvals

WHO Utilizes Pathogen Genomics For Global Disease Protection

24th May 2023
News

EMA Recommendations To Address Medicine Shortages In Europe

24th May 2023
Drug Development

Concerns Rise Over Shortage of Medical Products In The USA

23rd May 2023
News

Impact of Global Events On The Biopharmaceutical Industry

23rd May 2023

Latest News

Facilities & Operation

Switzerland Emerges As The Headquarters For European Biotech

25th May 2023
News

Genomics Market Growth In India To Accelerate Affordability

24th May 2023
FDA Approvals

EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

24th May 2023
FDA Approvals

WHO Utilizes Pathogen Genomics For Global Disease Protection

24th May 2023
News

EMA Recommendations To Address Medicine Shortages In Europe

24th May 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In